ABOUT US

Claire Padgett, Ph.D. joined Sanifit in October 2018 as our Senior Vice President, Development Operations and has extensive pharmaceutical drug development experience in global clinical research planning, execution, strategic development support, and operational management.  Previously she served as Senior Vice President of Clinical Operations at Mirati Therapeutics, Inc., and Vice President, Clinical Operations for Mast Therapeutics, Inc., Oncolytics Biotech, Inc., Cylene Pharmaceuticals and Conforma Therapeutics.. Working in small biotech and large pharmaceutical companies for over 30 years, Dr. Padgett has experience in clinical project management from first-in-human Phase 1 trials to large, complex global Phase 3 trials over a broad range of therapeutic areas including, oncology, hematology, CNS disease, endocrinology, gastrointestinal and pulmonary disorders, cardiovascular disease and rare disease research.  Claire has led several clinical development programs through product approval in biotechnology firms and CROs including Ligand Pharmaceuticals, Inc., Hoffmann-La Roche Ltd.,  Parexel International Corp., and IBRD/Syneos Health.  Claire holds a Ph.D. in Organizational Management and Leadership from Capella University, an M.S. in Biology and Business from Seton Hall University, and is a registered Medical Technologist (ASCP).  She supports undergraduate and graduate students and their research in San Diego as an IRB Board member at Point Loma Nazarene University